article thumbnail

Drug Discovery Informatics for Big Pharma: Key Webinar Insights

Collaborative Drug

This blog post summarizes the critical insights shared during this informative session. Dimitris Agrafiotis to discuss the current state and future directions of drug discovery informatics in large pharmaceutical organizations led by CDD's Founder and CEO, Dr. Barry Bunin.

Drugs 255
article thumbnail

Twelve Amazing Guest Blog Contributors!

addgene Blog

And we can’t think of any better way to start off our holiday season than by thanking the twelve guest bloggers and subject matter experts who have contributed to our blog in 2024. It’s a very thankful time of year for those of us at Addgene!

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Atlas doubles down on ‘disciplined’ biotech investing with latest fundraise

BioPharma Drive: Drug Pricing

The venture firm’s “modest” $450 million fund, a lower total than some of its peers recently raised, reflects lessons learned after Atlas grew too quickly, partner Bruce Booth wrote in a blog post.

171
171
article thumbnail

AI Unleashed: Transforming Drug Discovery from Theory to Practice

Plenge Gen

When I last wrote about AI on this blog three years ago, I spoke of it being a tool with the potential to transform scientific discovery, but the application I described was primarily theoretical. … The post AI Unleashed: Transforming Drug Discovery from Theory to Practice appeared first on Plenge Gen @rplenge.

Drugs 52
article thumbnail

Plasmids 101: Choosing an Antibiotic Resistance Gene

addgene Blog

In this blog, we’ll break down the mechanism of action of the most common antibiotic resistance genes and which applications are best (or worst) for each antibiotic. Plasmids need antibiotic resistance genes so that you can specifically isolate bacteria containing your constructs of interest.

143
143
article thumbnail

How to Scale Up with Cohere: Insights from Aidan Gomez

BenchSci

In this blog post, we delve into some key takeaways from our discussion, offering a valuable perspective for anyone interested in the future of AI.

Drugs 72
article thumbnail

CRISPR in the Clinic

addgene Blog

In 2014, we wrote a blog post on CRISPR’s potential for correcting monogenetic diseases. There can be no doubt that CRISPR/Cas9 technology has been a breakthrough for the genome-editing field and the greater scientific community.

Therapies 127